Chengdu Shi Endor Biological Engineering Technology Co., Ltd Report issue

Government Phase 2

Organization Overview

First Clinical Trial
2014
NCT02283489
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Renmiao Zhang

Active Ingredients

Drugs in Phase 2 Trials (3)

cisplatin (platinol) (1 trial)

endostatin adenovirus (1 trial)

paclitaxel (taxol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenoviridae Infections (Phase 2)

Head and Neck Neoplasms (Phase 2)

Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 3